Compare risks and benefits of common medications used for CMV Infection. Find the most popular drugs, view ratings and user reviews.

2024年2月8日 · Drugs used to treat CMV include ganciclovir (Cytovene or Vitrasert), valganciclovir (Valcyte), cidofovir (Vistide) and foscarnet . Side effects of ganciclovir and valganciclovir include the suppression of white blood cells (needed to fight infection), red blood cells (that carry oxygen) and platelets (that help the blood to clot).

The drug of choice for the treatment of CMV disease is intravenous ganciclovir, although valganciclovir may be used for nonsevere CMV treatment in selected cases. Ganciclovir is a...

2023年8月8日 · Cytomegalovirus (CMV) is a wide-spread virus, with manifestations ranging from asymptomatic to severe end-organ dysfunction in immunocompromised patients with congenital CMV disease. Human cytomegalovirus is a member of the viral family known as herpesviruses, Herpesviridae, or human herpesvirus-5 (HHV-5).

2022年3月23日 · Antiviral medications are the most common type of treatment. They can slow reproduction of the virus, but can't eliminate it. Researchers are studying new medications and vaccines to treat and prevent CMV .

Cytomegalovirus (CMV) or human CMV antiviral drugs are used for the treatment and prevention of CMV infections. Learn about how they work, usages, side effects, and a list of drugs.

There are currently four antiviral drugs licensed for the treatment of CMV infections: ganciclovir (GCV), valganciclovir (VGCV), foscarnet (FOS), and cidofovir (CDV). The role of these agents has evolved from the treatment of disease to include prevention of CMV infection and disease, primarily in solid organ transplant (SOT) and hematopoietic ...

If CMV is detected, an antiviral drug is given with the intention of suppressing virus replication below the level needed to cause viremia. A drug with moderate potency is required to keep CMV suppressed.

2024年1月24日 · Cytomegalovirus (CMV) infections may increase morbidity and mortality in immunocompromised patients. Until recently, standard antiviral drugs against CMV were limited to viral DNA polymerase inhibitors (val)ganciclovir, foscarnet and cidofovir with ...

Recent findings: Several new antiviral agents have emerged in recent times, including letermovir, maribavir, and brincidofovir, enhancing our ability to prevent and treat CMV. Recent data on novel agents will be reviewed, with an emphasis on recent guidelines and best practices.